DONACO INTERNATIONAL LIMITED - Announcements

Market Cap $35.82M Add to my watchlist

Consumer Cyclical Resorts & Casinos

Donaco International Limited is an Australia-based company, which operates leisure and... Donaco International Limited is an Australia-based company, which operates leisure and hospitality businesses across the Asia Pacific region. The Company’s segments include Casino Operations-Vietnam, Casino Operations-Cambodia, and Corporate Operations. The Casino Operations-Vietnam segment is comprised of the Aristo International Hotel operating in Vietnam. These operations include hotel accommodation, and gaming and leisure facilities. The Casino Operations-Cambodia segment comprises the Star Vegas Resort and Club, operating in Cambodia. Its operations include hotel accommodation and gaming and leisure facilities. The Corporate Operations segment consists of development and implementation of corporate strategy, commercial negotiations, corporate finance, treasury, management accounting, corporate governance, and investor relations functions. Its Star Vegas Resort and Club is a casino resort in Poipet. The Aristo International Hotel is located on the border between China and Vietnam.More

Announcements

Filter Results

All Price Sensitive Only

Filters [Clear]

Price Sensitive: Yes

DNA	Quarterly Activities and Cashflow Reports	PRICE SENSITIVE	25/10/24	597.47KB	Share
DNA	FY24 Results Presentation	PRICE SENSITIVE	30/08/24	519.55KB	Share
DNA	FY24 Results Commentary	PRICE SENSITIVE	30/08/24	236KB	Share
DNA	Preliminary Final Report	PRICE SENSITIVE	30/08/24	327.21KB	Share
DNA	Quarterly Activities and Cashflow Reports	PRICE SENSITIVE	26/07/24	641.05KB	Share
DNA	Quarterly Activities and Cashflow Reports	PRICE SENSITIVE	24/04/24	456.41KB	Share
DNA	1H FY24 Investor Presentation	PRICE SENSITIVE	28/02/24	1.55MB	Share
DNA	1H FY24 Results Summary	PRICE SENSITIVE	28/02/24	235.29KB	Share
DNA	Appendix 4D and Half Year Financial Report	PRICE SENSITIVE	28/02/24	700.6KB	Share
DNA	Quarterly Activities and Cashflow Reports	PRICE SENSITIVE	30/01/24	533.09KB	Share
DNA	Quarterly Activities and Cashflow Reports	PRICE SENSITIVE	30/10/23	528.4KB	Share
DNA	FY23 Results Presentation	PRICE SENSITIVE	31/08/23	859.25KB	Share
DNA	FY23 Results Commentary	PRICE SENSITIVE	31/08/23	209.71KB	Share
DNA	Preliminary Final Report	PRICE SENSITIVE	31/08/23	1.33MB	Share
DNA	Quarterly Activities Report	PRICE SENSITIVE	31/07/23	262.7KB	Share
DNA	Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/07/23	277.11KB	Share
DNA	Quarterly Activities Report	PRICE SENSITIVE	28/04/23	247.89KB	Share
DNA	Appendix 4C Cash Flow Report	PRICE SENSITIVE	28/04/23	218.42KB	Share
DNA	1H FY23 Results Summary	PRICE SENSITIVE	01/03/23	190.9KB	Share
DNA	Appendix 4D and Half Year Financial Report	PRICE SENSITIVE	28/02/23	1.06MB	Share
DNA	Quarterly Activities Report	PRICE SENSITIVE	31/01/23	334.69KB	Share
DNA	Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/01/23	219.24KB	Share
DNA	Appendix 4C Cash Flow Report (Amended)	PRICE SENSITIVE	31/10/22	427.26KB	Share
DNA	Quarterly Activities Report	PRICE SENSITIVE	28/10/22	243.05KB	Share
DNA	Appendix 4C Cash Flow Report	PRICE SENSITIVE	28/10/22	220.87KB	Share
DNA	Response to Price Query	PRICE SENSITIVE	05/10/22	374.66KB	Share
DNA	FY22 Results Presentation	PRICE SENSITIVE	30/08/22	1.32MB	Share
DNA	FY22 Results Commentary	PRICE SENSITIVE	30/08/22	296.76KB	Share
DNA	Preliminary Final Report	PRICE SENSITIVE	30/08/22	291.75KB	Share
DNA	Quarterly Activities Report	PRICE SENSITIVE	29/07/22	241.63KB	Share
DNA	Appendix 4C Cash Flow Report	PRICE SENSITIVE	29/07/22	224.32KB	Share
DNA	Star Vegas Casino Operations to Resume	PRICE SENSITIVE	17/06/22	159.45KB	Share
DNA	Loan Facility for Continued Balance Sheet Protection	PRICE SENSITIVE	02/05/22	194.96KB	Share
DNA	Quarterly Activities Report	PRICE SENSITIVE	29/04/22	234.47KB	Share
DNA	Appendix 4C Cash Flow Report	PRICE SENSITIVE	29/04/22	238.26KB	Share
DNA	1H FY22 Investor Presentation	PRICE SENSITIVE	28/02/22	1018.22KB	Share
DNA	1H FY22 Results Summary	PRICE SENSITIVE	28/02/22	187.3KB	Share
DNA	Appendix 4D and Half Year Financial Report	PRICE SENSITIVE	28/02/22	629.32KB	Share
DNA	Quarterly Activities Report & Appendix 4C - 31 December 2021	PRICE SENSITIVE	31/01/22	421.23KB	Share
DNA	Appendix 4C Cash Flow Report	PRICE SENSITIVE	29/10/21	247.45KB	Share
DNA	Quarterly Activities Report	PRICE SENSITIVE	29/10/21	244.64KB	Share
DNA	FY21 Results Commentary	PRICE SENSITIVE	31/08/21	213.28KB	Share
DNA	Appendix 4E and Preliminary Final Report	PRICE SENSITIVE	31/08/21	185.21KB	Share
DNA	Quarterly Activities Report	PRICE SENSITIVE	30/07/21	239.22KB	Share
DNA	Appendix 4C Cash Flow Report	PRICE SENSITIVE	30/07/21	152.9KB	Share
DNA	Status of Mega Bank Facility	PRICE SENSITIVE	01/07/21	163.56KB	Share
DNA	Quarterly Activities Report & Appendix 4C - 31 March 2021	PRICE SENSITIVE	30/04/21	505.58KB	Share
DNA	Temporary Closure of Star Vegas	PRICE SENSITIVE	28/04/21	152.66KB	Share
DNA	1H FY21 Results Summary	PRICE SENSITIVE	26/02/21	210.13KB	Share
DNA	Appendix 4D and Half Year Financial Report	PRICE SENSITIVE	26/02/21	545.53KB	Share
DNA	Quarterly Activities Report & Appendix 4C - 31 December 2020	PRICE SENSITIVE	29/01/21	474.53KB	Share
DNA	Lender approval received for Star Vegas settlement	PRICE SENSITIVE	22/12/20	155.78KB	Share
DNA	AGM 2020 - CEO Presentation	PRICE SENSITIVE	21/12/20	1.03MB	Share
DNA	DNA returns to positive EBITDA as COVID-19 impacts subside	PRICE SENSITIVE	18/12/20	171.48KB	Share
DNA	Quarterly Activities Report & Appendix 4C - 30 Sept 2020	PRICE SENSITIVE	30/10/20	1022.05KB	Share
DNA	Preliminary Final Report	PRICE SENSITIVE	01/09/20	361.69KB	Share
DNA	Quarterly Activities Report & Appendix 4C - 30 June 2020	PRICE SENSITIVE	31/07/20	451.24KB	Share
DNA	Donaco successfully completes Entitlement Offer	PRICE SENSITIVE	27/07/20	164.86KB	Share
DNA	Entitlement Issue Prospectus	PRICE SENSITIVE	03/07/20	554.4KB	Share
DNA	Non-Renounceable Entitlement Offer to Raise $14.4m	PRICE SENSITIVE	03/07/20	169.88KB	Share
DNA	Donaco Receives Lender Support	PRICE SENSITIVE	15/06/20	174.26KB	Share
DNA	Reopening of Aristo International Hotel Casino Operations	PRICE SENSITIVE	13/05/20	171.56KB	Share
DNA	Quarterly Activities Report & Appendix 4C	PRICE SENSITIVE	30/04/20	462.67KB	Share
DNA	Extension of Temporary Closure of Aristo Hotel Casino Ops	PRICE SENSITIVE	21/04/20	172.6KB	Share
DNA	Update on Progress of Star Vegas Settlement	PRICE SENSITIVE	17/04/20	192.9KB	Share
DNA	Temporary Closure of Aristo Hotel Casino Operations	PRICE SENSITIVE	01/04/20	137.21KB	Share
DNA	Temporary Closure of DNA Star Vegas Casino Operations	PRICE SENSITIVE	31/03/20	138.31KB	Share
DNA	Conclusion of Negotiations and Settlement with Thai Vendor	PRICE SENSITIVE	03/03/20	189.12KB	Share
DNA	Appendix 4D and Half Year Financial Report	PRICE SENSITIVE	28/02/20	831.98KB	Share
DNA	Update on Litigation Matters	PRICE SENSITIVE	03/02/20	723.03KB	Share
DNA	December Quarter Trading Update & Appendix 4C	PRICE SENSITIVE	31/01/20	594.09KB	Share
DNA	Reinstatement to Official Quotation	PRICE SENSITIVE	09/12/19	296.25KB	Share
DNA	Donaco Appoints Non-Executive Directors	PRICE SENSITIVE	09/12/19	755.32KB	Share
DNA	Resignation of CEO	PRICE SENSITIVE	05/12/19	140KB	Share
DNA	Suspension from Official Quotation	PRICE SENSITIVE	02/12/19	530.36KB	Share
DNA	Pause in Trading	PRICE SENSITIVE	02/12/19	116.32KB	Share
DNA	DNA Panel Receives Application	PRICE SENSITIVE	04/11/19	159.37KB	Share
DNA	September Quarter 2019 Trading Update	PRICE SENSITIVE	18/10/19	381.33KB	Share
DNA	FY19 Full Year Results Announcement (Appendix 4E)	PRICE SENSITIVE	28/08/19	347.52KB	Share
DNA	Decision in Cambodian Lease Arbitration	PRICE SENSITIVE	22/08/19	268.42KB	Share
DNA	Refinancing of Mega Bank Loan	PRICE SENSITIVE	24/06/19	233.02KB	Share
DNA	Appointment of CEO	PRICE SENSITIVE	11/06/19	270.43KB	Share
DNA	TOV: DNA Declaration of UC and Orders	PRICE SENSITIVE	07/05/19	322.78KB	Share
DNA	Pause in Trading	PRICE SENSITIVE	07/05/19	116.96KB	Share
DNA	March Quarter 2019 Trading Update	PRICE SENSITIVE	26/04/19	377.99KB	Share
DNA	TOV:Donaco International Limited Panel Receives Application	PRICE SENSITIVE	08/04/19	237.93KB	Share
DNA	S&P DJI Announces March 2019 Quarterly Rebalance	PRICE SENSITIVE	08/03/19	175.31KB	Share
DNA	Investor Presentation	PRICE SENSITIVE	28/02/19	1.28MB	Share
DNA	Appendix 4D & Half Year Accounts	PRICE SENSITIVE	28/02/19	359.16KB	Share
DNA	December Quarter 2018 Trading Update	PRICE SENSITIVE	29/01/19	390.66KB	Share
DNA	Strategic Review	PRICE SENSITIVE	13/12/18	227.12KB	Share
DNA	Senior Management Changes	PRICE SENSITIVE	06/12/18	231.79KB	Share
DNA	AGM Addresses and Trading Update	PRICE SENSITIVE	29/11/18	395.68KB	Share
DNA	Donaco records $42.4m EBITDA for FY18	PRICE SENSITIVE	30/08/18	357.64KB	Share
DNA	Investor Presentation	PRICE SENSITIVE	30/08/18	1.56MB	Share
DNA	FY18 Results Announcement (Appendix 4E)	PRICE SENSITIVE	30/08/18	327.12KB	Share
DNA	Further Update on Legal Proceedings	PRICE SENSITIVE	29/06/18	228.27KB	Share
DNA	Update on Legal Proceedings	PRICE SENSITIVE	12/06/18	263.51KB	Share
DNA	March Quarter Trading Update	PRICE SENSITIVE	16/04/18	266.13KB	Share
DNA	Donaco Awarded Injunction to Freeze Thai Vendor's Shares	PRICE SENSITIVE	03/04/18	235.59KB	Share

DNA Quarterly Activities and Cashflow Reports
25/10/24	PRICE SENSITIVE	597.47KB	Share
DNA FY24 Results Presentation
30/08/24	PRICE SENSITIVE	519.55KB	Share
DNA FY24 Results Commentary
30/08/24	PRICE SENSITIVE	236KB	Share
DNA Preliminary Final Report
30/08/24	PRICE SENSITIVE	327.21KB	Share
DNA Quarterly Activities and Cashflow Reports
26/07/24	PRICE SENSITIVE	641.05KB	Share
DNA Quarterly Activities and Cashflow Reports
24/04/24	PRICE SENSITIVE	456.41KB	Share
DNA 1H FY24 Investor Presentation
28/02/24	PRICE SENSITIVE	1.55MB	Share
DNA 1H FY24 Results Summary
28/02/24	PRICE SENSITIVE	235.29KB	Share
DNA Appendix 4D and Half Year Financial Report
28/02/24	PRICE SENSITIVE	700.6KB	Share
DNA Quarterly Activities and Cashflow Reports
30/01/24	PRICE SENSITIVE	533.09KB	Share
DNA Quarterly Activities and Cashflow Reports
30/10/23	PRICE SENSITIVE	528.4KB	Share
DNA FY23 Results Presentation
31/08/23	PRICE SENSITIVE	859.25KB	Share
DNA FY23 Results Commentary
31/08/23	PRICE SENSITIVE	209.71KB	Share
DNA Preliminary Final Report
31/08/23	PRICE SENSITIVE	1.33MB	Share
DNA Quarterly Activities Report
31/07/23	PRICE SENSITIVE	262.7KB	Share
DNA Appendix 4C Cash Flow Report
31/07/23	PRICE SENSITIVE	277.11KB	Share
DNA Quarterly Activities Report
28/04/23	PRICE SENSITIVE	247.89KB	Share
DNA Appendix 4C Cash Flow Report
28/04/23	PRICE SENSITIVE	218.42KB	Share
DNA 1H FY23 Results Summary
01/03/23	PRICE SENSITIVE	190.9KB	Share
DNA Appendix 4D and Half Year Financial Report
28/02/23	PRICE SENSITIVE	1.06MB	Share
DNA Quarterly Activities Report
31/01/23	PRICE SENSITIVE	334.69KB	Share
DNA Appendix 4C Cash Flow Report
31/01/23	PRICE SENSITIVE	219.24KB	Share
DNA Appendix 4C Cash Flow Report (Amended)
31/10/22	PRICE SENSITIVE	427.26KB	Share
DNA Quarterly Activities Report
28/10/22	PRICE SENSITIVE	243.05KB	Share
DNA Appendix 4C Cash Flow Report
28/10/22	PRICE SENSITIVE	220.87KB	Share
DNA Response to Price Query
05/10/22	PRICE SENSITIVE	374.66KB	Share
DNA FY22 Results Presentation
30/08/22	PRICE SENSITIVE	1.32MB	Share
DNA FY22 Results Commentary
30/08/22	PRICE SENSITIVE	296.76KB	Share
DNA Preliminary Final Report
30/08/22	PRICE SENSITIVE	291.75KB	Share
DNA Quarterly Activities Report
29/07/22	PRICE SENSITIVE	241.63KB	Share
DNA Appendix 4C Cash Flow Report
29/07/22	PRICE SENSITIVE	224.32KB	Share
DNA Star Vegas Casino Operations to Resume
17/06/22	PRICE SENSITIVE	159.45KB	Share
DNA Loan Facility for Continued Balance Sheet Protection
02/05/22	PRICE SENSITIVE	194.96KB	Share
DNA Quarterly Activities Report
29/04/22	PRICE SENSITIVE	234.47KB	Share
DNA Appendix 4C Cash Flow Report
29/04/22	PRICE SENSITIVE	238.26KB	Share
DNA 1H FY22 Investor Presentation
28/02/22	PRICE SENSITIVE	1018.22KB	Share
DNA 1H FY22 Results Summary
28/02/22	PRICE SENSITIVE	187.3KB	Share
DNA Appendix 4D and Half Year Financial Report
28/02/22	PRICE SENSITIVE	629.32KB	Share
DNA Quarterly Activities Report & Appendix 4C - 31 December 2021
31/01/22	PRICE SENSITIVE	421.23KB	Share
DNA Appendix 4C Cash Flow Report
29/10/21	PRICE SENSITIVE	247.45KB	Share
DNA Quarterly Activities Report
29/10/21	PRICE SENSITIVE	244.64KB	Share
DNA FY21 Results Commentary
31/08/21	PRICE SENSITIVE	213.28KB	Share
DNA Appendix 4E and Preliminary Final Report
31/08/21	PRICE SENSITIVE	185.21KB	Share
DNA Quarterly Activities Report
30/07/21	PRICE SENSITIVE	239.22KB	Share
DNA Appendix 4C Cash Flow Report
30/07/21	PRICE SENSITIVE	152.9KB	Share
DNA Status of Mega Bank Facility
01/07/21	PRICE SENSITIVE	163.56KB	Share
DNA Quarterly Activities Report & Appendix 4C - 31 March 2021
30/04/21	PRICE SENSITIVE	505.58KB	Share
DNA Temporary Closure of Star Vegas
28/04/21	PRICE SENSITIVE	152.66KB	Share
DNA 1H FY21 Results Summary
26/02/21	PRICE SENSITIVE	210.13KB	Share
DNA Appendix 4D and Half Year Financial Report
26/02/21	PRICE SENSITIVE	545.53KB	Share
DNA Quarterly Activities Report & Appendix 4C - 31 December 2020
29/01/21	PRICE SENSITIVE	474.53KB	Share
DNA Lender approval received for Star Vegas settlement
22/12/20	PRICE SENSITIVE	155.78KB	Share
DNA AGM 2020 - CEO Presentation
21/12/20	PRICE SENSITIVE	1.03MB	Share
DNA DNA returns to positive EBITDA as COVID-19 impacts subside
18/12/20	PRICE SENSITIVE	171.48KB	Share
DNA Quarterly Activities Report & Appendix 4C - 30 Sept 2020
30/10/20	PRICE SENSITIVE	1022.05KB	Share
DNA Preliminary Final Report
01/09/20	PRICE SENSITIVE	361.69KB	Share
DNA Quarterly Activities Report & Appendix 4C - 30 June 2020
31/07/20	PRICE SENSITIVE	451.24KB	Share
DNA Donaco successfully completes Entitlement Offer
27/07/20	PRICE SENSITIVE	164.86KB	Share
DNA Entitlement Issue Prospectus
03/07/20	PRICE SENSITIVE	554.4KB	Share
DNA Non-Renounceable Entitlement Offer to Raise $14.4m
03/07/20	PRICE SENSITIVE	169.88KB	Share
DNA Donaco Receives Lender Support
15/06/20	PRICE SENSITIVE	174.26KB	Share
DNA Reopening of Aristo International Hotel Casino Operations
13/05/20	PRICE SENSITIVE	171.56KB	Share
DNA Quarterly Activities Report & Appendix 4C
30/04/20	PRICE SENSITIVE	462.67KB	Share
DNA Extension of Temporary Closure of Aristo Hotel Casino Ops
21/04/20	PRICE SENSITIVE	172.6KB	Share
DNA Update on Progress of Star Vegas Settlement
17/04/20	PRICE SENSITIVE	192.9KB	Share
DNA Temporary Closure of Aristo Hotel Casino Operations
01/04/20	PRICE SENSITIVE	137.21KB	Share
DNA Temporary Closure of DNA Star Vegas Casino Operations
31/03/20	PRICE SENSITIVE	138.31KB	Share
DNA Conclusion of Negotiations and Settlement with Thai Vendor
03/03/20	PRICE SENSITIVE	189.12KB	Share
DNA Appendix 4D and Half Year Financial Report
28/02/20	PRICE SENSITIVE	831.98KB	Share
DNA Update on Litigation Matters
03/02/20	PRICE SENSITIVE	723.03KB	Share
DNA December Quarter Trading Update & Appendix 4C
31/01/20	PRICE SENSITIVE	594.09KB	Share
DNA Reinstatement to Official Quotation
09/12/19	PRICE SENSITIVE	296.25KB	Share
DNA Donaco Appoints Non-Executive Directors
09/12/19	PRICE SENSITIVE	755.32KB	Share
DNA Resignation of CEO
05/12/19	PRICE SENSITIVE	140KB	Share
DNA Suspension from Official Quotation
02/12/19	PRICE SENSITIVE	530.36KB	Share
DNA Pause in Trading
02/12/19	PRICE SENSITIVE	116.32KB	Share
DNA DNA Panel Receives Application
04/11/19	PRICE SENSITIVE	159.37KB	Share
DNA September Quarter 2019 Trading Update
18/10/19	PRICE SENSITIVE	381.33KB	Share
DNA FY19 Full Year Results Announcement (Appendix 4E)
28/08/19	PRICE SENSITIVE	347.52KB	Share
DNA Decision in Cambodian Lease Arbitration
22/08/19	PRICE SENSITIVE	268.42KB	Share
DNA Refinancing of Mega Bank Loan
24/06/19	PRICE SENSITIVE	233.02KB	Share
DNA Appointment of CEO
11/06/19	PRICE SENSITIVE	270.43KB	Share
DNA TOV: DNA Declaration of UC and Orders
07/05/19	PRICE SENSITIVE	322.78KB	Share
DNA Pause in Trading
07/05/19	PRICE SENSITIVE	116.96KB	Share
DNA March Quarter 2019 Trading Update
26/04/19	PRICE SENSITIVE	377.99KB	Share
DNA TOV:Donaco International Limited Panel Receives Application
08/04/19	PRICE SENSITIVE	237.93KB	Share
DNA S&P DJI Announces March 2019 Quarterly Rebalance
08/03/19	PRICE SENSITIVE	175.31KB	Share
DNA Investor Presentation
28/02/19	PRICE SENSITIVE	1.28MB	Share
DNA Appendix 4D & Half Year Accounts
28/02/19	PRICE SENSITIVE	359.16KB	Share
DNA December Quarter 2018 Trading Update
29/01/19	PRICE SENSITIVE	390.66KB	Share
DNA Strategic Review
13/12/18	PRICE SENSITIVE	227.12KB	Share
DNA Senior Management Changes
06/12/18	PRICE SENSITIVE	231.79KB	Share
DNA AGM Addresses and Trading Update
29/11/18	PRICE SENSITIVE	395.68KB	Share
DNA Donaco records $42.4m EBITDA for FY18
30/08/18	PRICE SENSITIVE	357.64KB	Share
DNA Investor Presentation
30/08/18	PRICE SENSITIVE	1.56MB	Share
DNA FY18 Results Announcement (Appendix 4E)
30/08/18	PRICE SENSITIVE	327.12KB	Share
DNA Further Update on Legal Proceedings
29/06/18	PRICE SENSITIVE	228.27KB	Share
DNA Update on Legal Proceedings
12/06/18	PRICE SENSITIVE	263.51KB	Share
DNA March Quarter Trading Update
16/04/18	PRICE SENSITIVE	266.13KB	Share
DNA Donaco Awarded Injunction to Freeze Thai Vendor's Shares
03/04/18	PRICE SENSITIVE	235.59KB	Share

REFRESH

(20min delay)
Last 2.9¢		Change -0.001(3.33%)		Mkt cap ! $35.82M

Open	High	Low	Value	Volume
2.9¢	2.9¢	2.9¢	$10.79K	372.2K

Buyers (Bids)

No.	Vol.	Price($)
1	59465	2.9¢

Sellers (Offers)

Price($)	Vol.	No.
3.0¢	153300	3

View Market Depth

No.	Vol.	Price($)
1	59465	0.029
3	109469	0.028
1	100000	0.027
1	134000	0.026
3	417142	0.025

Price($)	Vol.	No.
0.030	153300	3
0.031	499883	2
0.032	500000	1
0.033	330084	2
0.034	237420	3

Last trade - 15.23pm 08/11/2024 (20 minute delay)

DNA (ASX) Chart

DONACO INTERNATIONAL LIMITED - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories